De Meyer S - Search Results

1

Incidence of virological failure and emergence of resistance with twice-daily vs every 8-h administration of telaprevir in the OPTIMIZE study.

Dierynck I, Ghys A, Witek J, Luo D, Janssen K, Daems B, Picchio G, Buti M, De Meyer S. Dierynck I, et al. Among authors: de meyer s. J Viral Hepat. 2014 Dec;21(12):835-42. doi: 10.1111/jvh.12347. J Viral Hepat. 2014. PMID: 25402544 Clinical Trial.

2

Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients".

Picchio G, De Meyer S, de Béthune MP. Picchio G, et al. Among authors: de bethune mp, de meyer s. AIDS. 2008 Jan 2;22(1):165-7. doi: 10.1097/QAD.0b013e3282f2be42. AIDS. 2008. PMID: 18090413 Review. No abstract available.

3

Resistance profile of darunavir: combined 24-week results from the POWER trials.

de Meyer S, Vangeneugden T, van Baelen B, de Paepe E, van Marck H, Picchio G, Lefebvre E, de Béthune MP. de Meyer S, et al. Among authors: de bethune mp, de paepe e. AIDS Res Hum Retroviruses. 2008 Mar;24(3):379-88. doi: 10.1089/aid.2007.0173. AIDS Res Hum Retroviruses. 2008. PMID: 18327986 Clinical Trial.

4

Influence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial.

De Meyer S, Hill A, Picchio G, DeMasi R, De Paepe E, de Béthune MP. De Meyer S, et al. Among authors: de bethune mp, de paepe e. J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):563-4. doi: 10.1097/QAI.0b013e318183ac9c. J Acquir Immune Defic Syndr. 2008. PMID: 19202459 Clinical Trial. No abstract available.

5

Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients.

De Meyer S, Lathouwers E, Dierynck I, De Paepe E, Van Baelen B, Vangeneugden T, Spinosa-Guzman S, Lefebvre E, Picchio G, de Béthune MP. De Meyer S, et al. Among authors: de bethune mp, de paepe e. AIDS. 2009 Sep 10;23(14):1829-40. doi: 10.1097/QAD.0b013e32832cbcec. AIDS. 2009. PMID: 19474650 Clinical Trial.

6

Etravirine limits the emergence of darunavir and other protease inhibitor resistance-associated mutations in the DUET trials.

Peeters M, Vingerhoets J, Tambuyzer L, Azijn H, Hill A, De Meyer S, Picchio G. Peeters M, et al. Among authors: de meyer s. AIDS. 2010 Mar 27;24(6):921-4. doi: 10.1097/QAD.0b013e328336ac2a. AIDS. 2010. PMID: 20160633

7

Short communication: activity of etravirine on different HIV type 1 subtypes: in vitro susceptibility in treatment-naive patients and week 48 pooled DUET study data.

Vingerhoets J, Azijn H, Tambuyzer L, Dierynck I, De Meyer S, Rimsky L, Nijs S, De Smedt G, de Béthune MP, Picchio G. Vingerhoets J, et al. Among authors: de bethune mp, de smedt g, de meyer s. AIDS Res Hum Retroviruses. 2010 Jun;26(6):621-4. doi: 10.1089/aid.2009.0239. AIDS Res Hum Retroviruses. 2010. PMID: 20507207

8

In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients.

Dierynck I, De Meyer S, Lathouwers E, Vanden Abeele C, Van De Casteele T, Spinosa-Guzman S, de Béthune MP, Picchio G. Dierynck I, et al. Among authors: de bethune mp, de meyer s. Antivir Ther. 2010;15(8):1161-9. doi: 10.3851/IMP1697. Antivir Ther. 2010. PMID: 21149923 Clinical Trial.

9

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study: 96-week analysis.

Lathouwers E, De Meyer S, Dierynck I, Van de Casteele T, Lavreys L, de Béthune MP, Picchio G. Lathouwers E, et al. Among authors: de bethune mp, de meyer s. Antivir Ther. 2011;16(1):99-108. doi: 10.3851/IMP1719. Antivir Ther. 2011. PMID: 21311113 Clinical Trial.

10

Telaprevir for retreatment of HCV infection.

Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, Roberts S, Focaccia R, Younossi Z, Foster GR, Horban A, Ferenci P, Nevens F, Müllhaupt B, Pockros P, Terg R, Shouval D, van Hoek B, Weiland O, Van Heeswijk R, De Meyer S, Luo D, Boogaerts G, Polo R, Picchio G, Beumont M; REALIZE Study Team. Zeuzem S, et al. Among authors: de meyer s. N Engl J Med. 2011 Jun 23;364(25):2417-28. doi: 10.1056/NEJMoa1013086. N Engl J Med. 2011. PMID: 21696308 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters